In conclusion, our research shows that ginsenoside Rg3 can reduce the EGFR copy number, especially in the critical exons of EGFR-mutated lung adenocarcinoma cells, and decrease the levels of EGFR proteins, thus enhancing the effectiveness of EGFR-TKIs when used in combination. The gene discussed is EGFR; the disease is lung adenocarcinoma.